Old Web
English
Sign In
Acemap
>
authorDetail
>
Charles A Cruze
Charles A Cruze
Pathology
Phosphatidylserine
Medicine
Toxicokinetics
Dosing
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Absence of indicators of hypercoagulability and antiphospholipid syndrome in bxq-350 first in human study.
2018
Journal of Clinical Oncology
Charles A Cruze
Olivier Rixe
John C. Morris
Vinay K. Puduvalli
John L. Villano
Trisha M. Wise-Draper
Angela N. Johnson
Robert Wesolowski
Show All
Source
Cite
Save
Citations (1)
Allometric scaling of preclinical pharmacokinetic and toxicokinetic parameters to predict clinical pharmacokinetics of BXQ-350 saposin C protein-phosphatidylserine nanovesicles.
2018
Journal of Clinical Oncology
Charles A Cruze
Olivier Rixe
John C. Morris
Vinay K. Puduvalli
John L. Villano
Trisha M. Wise-Draper
Angela N. Johnson
Robert Wesolowski
Gary A. Thompson
Show All
Source
Cite
Save
Citations (0)
1